Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
Neuro Resus

Neuro Resus

Oliver Flower

Podcasts on topics relevant to intensive care medicine
Share icon

All episodes

Best episodes

Seasons

Top 10 Neuro Resus Episodes

Goodpods has curated a list of the 10 best Neuro Resus episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Neuro Resus for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Neuro Resus episode by adding your comments to the episode page.

Neuro Resus - Post Resus Care in Paediatric ICU
play

07/29/19 • 36 min

A podcast by two intensivists from Westmead PICU on post resuscitation care.

bookmark
plus icon
share episode
Neuro Resus - Blood Pressure Targets
play

10/10/18 • 21 min

Blood Pressure (BP) is one of the vital hemodynamic parameters that we often aim to optimize for critically ill patients. Our decisions regarding BP targets, and ensuing use (or avoidance) of vasopressor agents, may directly impact on outcomes for these patients. Despite being a fundamental tenet of critical care, there is a lack of quality evidence to suggest optimal BP targets or to guide the use of vasopressors for individual patients with shock. A mean arterial BP (MAP) of 65-70 mmHg is an often-cited initial BP target for patients during vasopressor therapy. Use of vasopressors to maintain MAP of 65 mmHg or greater remains one of the core clinical criteria in the new definition of septic shock. However, such standard targets are unlikely to be applicable to all patients, many of whom would have a basal MAP higher than 65-70 mmHg, often to a varying degree, during their usual pre-illness state. Therefore, a vasopressor therapy guided by standard BP thresholds may result in a variable degree of untreated relative hypotension, which is associated with new-onset acute kidney injury (AKI). From a physiological standpoint, any relative reduction in net perfusion pressure across an organ’s vasculature can overwhelm its autoregulatory mechanisms, which are already under stress during a shock state. In a recent major RCT, among patients with chronic hypertension, targeting a higher MAP of 80-85 mmHg, versus 65-70 mmHg, showed a lower incidence of subsequent AKI, but with no difference in mortality. However, this RCT did not take patients’ pre-illness basal BP into account, making it difficult to extrapolate these results to those patients with chronic hypertension, who usually have a well-controlled basal BP, or to those patients, who although have a higher-than-normal basal BP but are not formally diagnosed with hypertension. Accounting for a patient’s pre-illness basal BP can minimize variation in the degree of untreated relative hypotension that is often inadvertently accepted in conventional care. It is a simple, but untested, strategy. Further, new tools that can monitor cerebral autoregulation in real-time are on the horizon and have shown some promise in suggesting an optimal BP for individual patients with shock. This technology can further help adjust the initial BP target as a patient deteriorates or recovers from the shock state.

bookmark
plus icon
share episode
Neuro Resus - Top 10 papers of recent times
play

09/19/18 • 27 min

There has been a potpourri of papers released in the last 12 months of interest to Intensivists. Some have solved the great mysteries of the universe, some have sparked the interest for more high-quality research and others have left us scratching our heads. This talk will give a snapshot of the Top 10 Critical Care papers of the last year.

bookmark
plus icon
share episode
Neuro Resus - Patient selection and functional outcomes
play

08/20/18 • 18 min

Introduction: Recent times have witnessed almost half, or sometimes more cardiac surgical procedures are performed in patients above 75 years of age. Traditionally, the EuroSCORE II and STS risk scoring systems have been widely used across the globe. Extensive reviews have shown that EuroSCORE II probably overestimates the perioperative risk at lower score levels while the STS score tends to underestimate the risk.

Frailty is a broad term that encircles aspects of nutrition, lack of agility, inactivity, lack of strength and wasting; and is seen in 25-50% of elderly patients. It has been defined as a geriatric syndrome reflecting a state of reduced physiological reserve and increased vulnerability to poor resolution of homeostasis after a stressor event. Conversely, pre-frailty, which is potentially reversible, is associated with higher risk of older adults developing cardiovascular disease.

Frailty assessment includes a variety of physical and cognitive tests, functional assessments and evaluating nutritional status. Literature has highlighted what is referred to as the ‘obesity paradox’, meaning obese patients with heart failure fair better than leaner patients, possibly because they have more metabolic reserve and also because weight loss in itself is a risk factor for frailty.

Patient Selection: To comprehensively assess a patient, factors that describe the biological status of the patient should be incorporated. There are various methods of assessment and modified Fried criteria or comprehensive assessment of frailty are a couple of systems commonly used.

Conclusion: Systematic reviews have shown that frail patients have higher chance of mortality, major adverse cardiac and cerebrovascular events and functional decline after cardiac surgery. A holistic assessment not only categorises patients into the apt risk category and hence match goals and treatments; but also, will pick up patients with pre-frailty who will benefit from multidisciplinary intervention and be better prepared for the intervention.

bookmark
plus icon
share episode
Neuro Resus - ECHO by the clinician
play

08/20/18 • 16 min

"The real benefit to the patient [of echocardiography] is not the technical skill, but rather the application of intellectual input... information, communication and teamwork are essential" Jos Roelandt, 1993

Of all the imaging techniques used in intensive care, echocardiography has come to the fore, in particular due to its accessibility, immediate availability and applicability as a point-of-care technique, thereby removing the risks of transportation of the critically ill. Over the preceding 20 years evidence has continued to emerge for its extended use in the acute/emergency setting, to the extent that it is now included in national and international guidelines relating to the universal definition of myocardial infarction, as well as in shock pathways, and as an adjunctive technique in advanced life support. Its potential scope is huge, with applications relating to monitoring, cardiac pathophysiology and coronary perfusion as well as its more evident use to define cardiac anatomy.

The three main uses of ultrasound to interrogate the heart relate to the way in which the technique is used: first, as an extension to the clinical examination using binary questions and 2D imaging only (focused cardiac ultrasound, FoCUS) which forms the basis of 'basic' techniques. Second, incorporating the full range of echocardiographic techniques for diagnostic capability (echocardiography), and third, selective application of the full range of techniques in order to answer specific questions raised in the critical care/emergency arena (targeted echocardiography). This includes speckle strain/strain-rate to determine abnormalities of myocardial function suggestive of myocarditis, calculation of myocardial electromechanical efficiency in order to maximise cardiac output, recognition of parameters that suggest restrictive right ventricular physiology, with the requirement for modification of ventilatory techniques and parameters, detection of myocardial ischaemia, estimation of LVEDP and LAP, and its application in the institution, monitoring and weaning of mechanical circulatory support.

Key questions for the clinician undertaking echocardiography in the critical/acute/emergency setting can be summarised in a checklist format, which includes:

Background questions:

  1. What is the clinical context?
  2. What does the treating clinician want to know (ie why won't the patient wean from mechanical ventilation? or is this pulmonary oedema, and if so, why?).
  3. Can echocardiography answer the required question, and what is the accuracy in this setting?
  4. What is the underlying diagnosis (cardiac and non-cardiac)?
  5. How is the patient being sedated/ventilated/supported

Specific echocardiographic data:

  1. What is limiting the cardiac output/elevating the venous pressure?
  2. Is the left atrial pressure elevated?
  3. Is the heart rate/AV delay/VV delay appropriate?
  4. Is there any other relevant information that the treating clinician needs to know that may inform planned interventions?

To reach its full potential in the critical arena demands therefore not only understanding of the whole range of echocardiographic techniques, but also the confounding factors that will be found in this setting, including filling status, ventilatory parameters, mechanical support and the use of vasoactive agents. Although frequently 'simplified' for application in FoCUS, expert echocardiography in this setting can be extremely challenging, and the potential to cause harm to the patient through misinterpretation should not be underestimated.

bookmark
plus icon
share episode

The right ventricle (RV) is not important, until it is. Under normal conditions RV function merely keeps central venous pressure low and delivers all the venous return per beat into the pulmonary circulation under low pressure. If pulmonary artery pressures increase due to pulmonary vascular disease (embolism, ARDS, COPD), over-distention (COPD, asthma) or ischemia (embolism, pulmonary hypertension), the RV rapidly dilates decreasing left ventricular (LV) diastolic compliance via ventricular interdependence. Most clinicians presume that the RV is merely a weaker version of the LV, but follows that same rules. But this in not true. Normally, RV filling occurs without any measurable change in RV distending pressure owing to conformational changes in its shape rather than distention of its wall fibers. This effect allows central venous pressure to remain low despite major dynamic change sin venous return associated with breathing. RV ejection is exquisitely dependent of RV ejection pressure. Thus, if disease processes increase pulmonary artery impedance then RV dilation and failure will eventually occur. Furthermore, most of RV coronary blood flow occurs during systole, unlike LV coronary blood flow, which primarily occurs in diastole. Thus, systemic hypotension or relative hypotension where in pulmonary artery pressures equal or exceed aortic pressure must cause RV ischemia. Clinically these findings carry a common end result. For cardiac output to increase RV volumes must increase. If increasing RV volumes also result in increasing filling pressures then RV over distention may be occurring causing RV free wall ischemia. If relative systemic hypotension exists then selective increases in arterial pressure will improve RV systolic function. Accordingly, fluid resuscitation, if associated with rapid increases in central venous pressure should be stopped until evidence of acute cor pulmonale is excluded. Acute cor pulmonale can be treated by improving LV systolic function, coronary perfusion pressure or reducing pulmonary artery outflow impedance. The normal response of the RV to slowly increasing pulmonary artery pressures is to increase its intrinsic contractility (Anrep effect), but if the pressure load exceeds such adaptation, RV hypertrophy develops in an asymmetric fashion initially in the infundibulum before progressing to the RV free wall and septum. In chronic RV failure, dilation and RV wall thinning occurs as the heart reverts to preload to sustain stroke volume (Starling effect). Importantly, all these effects and their response to therapies can be assessed at the bedside using echocardiography and pulmonary arterial catheterization.

bookmark
plus icon
share episode
Neuro Resus - Debate: Who should care for GUCH?
play

08/06/18 • 24 min

Debate: Who should care for GUCH?

Presenters: Dr Susanna Price & Dr Peta Alexander. Moderator: Dr Bennett Sheridan

bookmark
plus icon
share episode

Hepatic resections are complex surgical procedures harboring a significant risk for complications. In line with the continued development of liver surgery, hepatic resections tend to be more complex and extensive, with to this associated enhanced risk for post-hepatectomy liver failure (PHLF). Despite these improvements in outcome after major liver resection, PHLF remains one of the most serious and fatal complication of major liver resection occurring in up to 8 % of the cases. Multiple factors increase the risk of PHLF but in clinical practice the risk of PHLF is closely associated with the assessment of the pre-operative Future Liver Remnant (FLR). Accordingly the prevention of PHLF is alleged to be affected by the induction of hypertrophy of the liver remnant via portal vein embolization or ligation if the expected functional left remnant in cases where the FLR is judged too small. An alternative therapeutic strategy is to perform a two-stage procedure allowing the FLR to grow after the first non-curative resection. Irrespective of these surgical-technical advancements, early recognition and initiation of supportive care is crucial to improve patient outcomes in PHLF. Despite its fatal consequences, the complexity behind the pathogenesis of PHLF remains poorly understood and treatment options (except for preventive measures) are limited. The advent of extra corporeal, albumin-based liver-dialysis system (Molecular Adsorbent Recirculating System, MARS) seemed to offer a treatment modality for patients with liver failure being either acute or acute on chronic (ACLF). The information on the use of MARS in PHLF is meager and basically no experiences have been reported with the use of well-defined criteria for liver failure. For instance Van de Kerkhove et al. reported on five patients treated with MARS due to unspecified PHLF, of whom 3 improved but only one survived. We have recently compiled our experience with MARS treatment for well-defined PHLF and found that four out of 13 patients survived (31%) three months postoperatively. However, this survival figure rose to 44% (4/9) if the analysis was confined to patients with primary PHLF fulfilling the Balzan criteria alone. These results formed the basis of a prospective clinical trial with the objective of evaluating early and consistent MARS treatment in patients with primary PHLF. Results from this study will be presented and discussed References Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Annals of surgery. 2005;242(6):824-8 Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. Asaio J. 1993;39(3):M621-5. Gilg S, Escorsell A, Fernandez J, Garcia-Valdecasas JC, Saraste L, Wahlin S Nowak G, Stromberg C, Lundell L, Isaksson B. Albumin dialysis with MARS in post-hepatectomy liver failure (PHLF): experiences from two HPB centers. Surgery Current Research, 2015, 6: 252.

bookmark
plus icon
share episode
Neuro Resus - Is life worth living? It depends on the liver
play

03/02/18 • 22 min

The patient with chronic liver disease presents a range of potential challenges when a severe intercurrent illness occurs or major surgery is required. Even well-compensated liver cirrhosis in high functioning patients renders such individuals vulnerable to a myriad of problems when physiological stressors occur. Severe acute liver failure is another clearly defined sydrome in which extremely rapid and complex multiple organ failure typically ensues. Whilst intensivists are familiar and adept with the management of other major organ failure, new acute liver failure or decompensated chronic liver disease is particularly difficult to manage due to the inherent breadth of roles that the liver has in maintaining health as well as the current lack of comprehensive support therapies other than organ transplantation. While effective artificial life-supports for severe respiratory, cardiac or renal failure are available in the intensive care setting, support for over liver failure is less straightforward. The failing liver inevitably and rapidly impact on every other organ system, necessitating a systematic and comprehensive approach when planning patient care. As with any dynamic and complex disease process, management is optimised when major clinical problems are anticipated and the detrimental impact is mitigated by the timely application of effective interventions. For patients with severe acute liver failure, a knowledge of the cause, disease trajectory, severity of organ failure as well as early interventions to prevent cerebral oedema are likely to improve outcomes. Specific treatments such as temperature management, respiratory support, osmotherapy and blood purification may be readily applied and reduce the risk of poor outcomes. In the setting of decompensated chronic liver disease, identifying reversible causes of deterioration and proactively managing the resulting predictable problems will ensure the best chance for recovery or stabilisation until subsequent transplantation. The majority of patients can be effectively managed in non-transplant centres, however it is also essential to identify those patients for whom orthotopic liver transplantation is the best or only option for survival. Early discussion with a transplant centre may assist intensivists in deciding who should be transferred and guide the timing of retrieval.

bookmark
plus icon
share episode
Neuro Resus - Burns

Burns

Neuro Resus

play

09/04/19 • 19 min

Dr Anthony Holley: Burns.

From CICM ASM PROGRAM 2019.

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does Neuro Resus have?

Neuro Resus currently has 441 episodes available.

What topics does Neuro Resus cover?

The podcast is about Social, Health & Fitness, Icu, Media, Care, Neurosurgery, Medicine, Podcasts, Education, Conference and Network.

What is the most popular episode on Neuro Resus?

The episode title 'aSAH: Dilating the Dogma of Vasospasm' is the most popular.

What is the average episode length on Neuro Resus?

The average episode length on Neuro Resus is 24 minutes.

How often are episodes of Neuro Resus released?

Episodes of Neuro Resus are typically released every 3 days.

When was the first episode of Neuro Resus?

The first episode of Neuro Resus was released on Apr 5, 2011.

Show more FAQ

Toggle view more icon

Comments